Market Cap 7.74B
Revenue (ttm) 2.57B
Net Income (ttm) -1.84B
EPS (ttm) N/A
PE Ratio 24.05
Forward PE 26.21
Profit Margin -71.86%
Debt to Equity Ratio 0.18
Volume 530,933
Avg Vol 375,502
Day's Range N/A - N/A
Shares Out 27.21M
Stochastic %K 87%
Beta 0.90
Analysts Sell
Price Target $320.80

Company Profile

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, q...

Industry: Medical Devices
Sector: Healthcare
Phone: 510 724 7000
Fax: 510 741 5817
Address:
1000 Alfred Nobel Drive, Hercules, United States
JohnMurphy989
JohnMurphy989 Aug. 4 at 1:17 PM
$BIO 🔥 QNTM just filed a $700M lawsuit vs CIBC & RBC for alleged price spoofing (2020-2024) Backed by real trading data, timestamps, and top law firms (working on contingency 💼) Market cap? Just $77M. If this sticks - QNTM could 5-10x. 🎯 Price Target: $35-$50 on any court traction or settlement buzz This isn't just a trade - it's a revenge rally waiting to explode
0 · Reply
Spicy_Trade
Spicy_Trade Aug. 3 at 4:29 PM
SpicyTrade Bio-Rad Laboratories, Inc. ( $BIO ) daily stock analysis https://youtu.be/85FMTC2bkmI?si=jWwDQ7Qy6YBrvpiJ
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 1 at 6:38 PM
$BIO Bio-Rad Labs rallied after crushing earnings expectations. Learn how process chromatography and ddPCR growth could power even bigger gains. https://biotechhealthx.com/biotech-news/bio-rad-labs-bio-smashes-earnings-estimates-is-the-stock-ready-to-explode/
0 · Reply
RoyClay580
RoyClay580 Aug. 1 at 4:59 PM
$BIO QNTM float paper, L2 tight — someone’s settin it up 🎯
0 · Reply
JosephAllison258
JosephAllison258 Aug. 1 at 4:55 PM
$BIO QNTM doesn’t hold like this unless it’s staged 📊
0 · Reply
topstockalerts
topstockalerts Aug. 1 at 3:46 PM
$BIO there she goes…🏦🏦
0 · Reply
RhondaDanger482
RhondaDanger482 Aug. 1 at 3:26 PM
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 3:23 PM
RBC Capital has adjusted their stance on Bio-Rad Laboratories ( $BIO ), setting the rating to Outperform with a target price of 387 → 409.
0 · Reply
AllenMatthews883
AllenMatthews883 Aug. 1 at 3:13 PM
$BIO Hearing chatter... someone knows something. No volume spike, but QNTM starting to feel heavy — like it’s being loaded. QNTM quietly positioning in two verticals — clinical biotech and private wellness. Lucid-MS is already scanning patients (MGH), and Unbuzzd’s Reg D raise is live with QNTM holding 25% equity, untouched. The float? Still paper thin. Volume? Silent. Insiders? Buying under the radar (check the filing). This doesn’t stay quiet forever. Still early - just barely.
0 · Reply
topstockalerts
topstockalerts Aug. 1 at 2:13 PM
Top Gainers PT2 $LXEH $TILE $ANTE $FDMT $BIO
0 · Reply
Latest News on BIO
Bio-Rad Reports Second-Quarter 2025 Financial Results

Jul 31, 2025, 4:15 PM EDT - 4 days ago

Bio-Rad Reports Second-Quarter 2025 Financial Results


Bio-Rad Reports First-Quarter 2025 Financial Results

May 1, 2025, 4:15 PM EDT - 3 months ago

Bio-Rad Reports First-Quarter 2025 Financial Results


Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 11:45 PM EST - 6 months ago

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript


Bio-Rad Reports Third-Quarter 2024 Financial Results

Oct 30, 2024, 4:15 PM EDT - 9 months ago

Bio-Rad Reports Third-Quarter 2024 Financial Results


Bio-Rad Reports Second-Quarter 2024 Financial Results

Aug 1, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Second-Quarter 2024 Financial Results


Bio-Rad Reports First-Quarter 2024 Financial Results

May 7, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports First-Quarter 2024 Financial Results


Bio-Rad Announces Life Science Group Management Changes

Apr 26, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Announces Life Science Group Management Changes


Bio-Rad's Chief Operating Officer Andrew Last to Retire

Apr 10, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad's Chief Operating Officer Andrew Last to Retire


Bio Rad Labs rises after posting upbeat fourth-quarter profit

Feb 15, 2024, 6:51 PM EST - 1 year ago

Bio Rad Labs rises after posting upbeat fourth-quarter profit


S&P 500 Stocks With the Most Upside

Dec 26, 2023, 11:29 AM EST - 1 year ago

S&P 500 Stocks With the Most Upside

APA APTV FSLR GM HAL LVS MRNA


6 Stock Picks in Healthcare for 2024

Dec 20, 2023, 3:07 PM EST - 1 year ago

6 Stock Picks in Healthcare for 2024

BMY CI HUM INCY MRNA


JohnMurphy989
JohnMurphy989 Aug. 4 at 1:17 PM
$BIO 🔥 QNTM just filed a $700M lawsuit vs CIBC & RBC for alleged price spoofing (2020-2024) Backed by real trading data, timestamps, and top law firms (working on contingency 💼) Market cap? Just $77M. If this sticks - QNTM could 5-10x. 🎯 Price Target: $35-$50 on any court traction or settlement buzz This isn't just a trade - it's a revenge rally waiting to explode
0 · Reply
Spicy_Trade
Spicy_Trade Aug. 3 at 4:29 PM
SpicyTrade Bio-Rad Laboratories, Inc. ( $BIO ) daily stock analysis https://youtu.be/85FMTC2bkmI?si=jWwDQ7Qy6YBrvpiJ
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 1 at 6:38 PM
$BIO Bio-Rad Labs rallied after crushing earnings expectations. Learn how process chromatography and ddPCR growth could power even bigger gains. https://biotechhealthx.com/biotech-news/bio-rad-labs-bio-smashes-earnings-estimates-is-the-stock-ready-to-explode/
0 · Reply
RoyClay580
RoyClay580 Aug. 1 at 4:59 PM
$BIO QNTM float paper, L2 tight — someone’s settin it up 🎯
0 · Reply
JosephAllison258
JosephAllison258 Aug. 1 at 4:55 PM
$BIO QNTM doesn’t hold like this unless it’s staged 📊
0 · Reply
topstockalerts
topstockalerts Aug. 1 at 3:46 PM
$BIO there she goes…🏦🏦
0 · Reply
RhondaDanger482
RhondaDanger482 Aug. 1 at 3:26 PM
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 3:23 PM
RBC Capital has adjusted their stance on Bio-Rad Laboratories ( $BIO ), setting the rating to Outperform with a target price of 387 → 409.
0 · Reply
AllenMatthews883
AllenMatthews883 Aug. 1 at 3:13 PM
$BIO Hearing chatter... someone knows something. No volume spike, but QNTM starting to feel heavy — like it’s being loaded. QNTM quietly positioning in two verticals — clinical biotech and private wellness. Lucid-MS is already scanning patients (MGH), and Unbuzzd’s Reg D raise is live with QNTM holding 25% equity, untouched. The float? Still paper thin. Volume? Silent. Insiders? Buying under the radar (check the filing). This doesn’t stay quiet forever. Still early - just barely.
0 · Reply
topstockalerts
topstockalerts Aug. 1 at 2:13 PM
Top Gainers PT2 $LXEH $TILE $ANTE $FDMT $BIO
0 · Reply
d_risk
d_risk Aug. 1 at 1:50 PM
$BIO - Bio-Rad Laboratories Inc. Class A Common Stock - 10Q - Updated Risk Factors BIO’s 2025 10-Q reveals heightened risks from complex global compliance, supply chain and innovation delays, geopolitical and economic instability, cyber and IT disruptions, currency volatility, regulatory shifts, organizational changes, tax reforms, ESG pressures, rising debt, and intensified litigation exposure. #Biotechnology #GeopoliticalInstability #Cybersecurity #SupplyChainRisk #GlobalCompliance 🟢 Added 🟠 Removed https://d-risk.ai/BIO/10-Q/2025-07-31
0 · Reply
topstockalerts
topstockalerts Aug. 1 at 12:11 PM
$BIO where's she going once market opens? ..🍾🍾 ..
0 · Reply
jbess22
jbess22 Aug. 1 at 1:05 AM
0 · Reply
John_Wick1234
John_Wick1234 Jul. 28 at 11:03 AM
$BIO Nice Double Bottom.
1 · Reply
JarvisFlow
JarvisFlow Jul. 15 at 11:00 AM
Wells Fargo updates rating for Bio-Rad Laboratories ( $BIO ) to Equal-Weight, target set at 340 → 360.
0 · Reply
Darbye
Darbye Jul. 14 at 5:31 PM
$HPIL $BIO Im not going to be able to watch the Shareholders conference. 😟 So, whomever does watch, please take notes or just remember the good stuff. 😆 Im sure theres a few of us that can't watch. Or just tell us that we're going to be Rich. 🤑 Thank you 🙏
2 · Reply
John_Wick1234
John_Wick1234 Jul. 14 at 12:54 PM
$BIO Double Bottom With Good Volume.
0 · Reply
ZacksResearch
ZacksResearch Jul. 14 at 12:43 PM
$BIO just launched 4 new ddPCR platforms — shares have risen 4% since the announcement. 🔍 Bio-Rad's new products, including the QX Continuum system, aim to strengthen its Life Science segment by offering unparalleled workflow simplicity and throughput capabilities. This expansion is expected to boost market sentiment around the stock. Discover the full story here 👉 https://www.zacks.com/stock/news/2579353/bio-rad-stock-climbs-following-the-launch-of-four-ddpcr-platforms?cid=sm-stocktwits-2-2579353-body-1496&ADID=SYND_STOCKTWITS_TWEET_2_2579353_BODY_1496
0 · Reply
ZacksResearch
ZacksResearch Jul. 14 at 11:08 AM
$BIO pops 4% on major product launch — is this the growth spark investors needed? The Stilla acquisition just paid off, powering the rollout of four new ddPCR systems and pushing the assay menu past 400K. Full story here 👉 https://www.zacks.com/stock/news/2579353/bio-rad-stock-climbs-following-the-launch-of-four-ddpcr-platforms?cid=sm-stocktwits-2-2579353-teaser-1461&ADID=SYND_STOCKTWITS_TWEET_2_2579353_TEASER_1461
0 · Reply
_CCS_
_CCS_ Jun. 23 at 7:53 PM
$BIO bull trap after trap
0 · Reply
leavens123
leavens123 May. 28 at 2:01 PM
$VERU not a matter of if, it’s when. This is bound to pass phase 2 and clinical. GLP1 is everywhere now. So muscle wasting from its use will need this big time. $SPRB $BIO $SBIO
0 · Reply
DerEins
DerEins May. 27 at 6:11 PM
$BIO Earnings have been good, upbeat the expected by 40%, the way down has been long for this now, if i look at the charts, a turningpoint might come.... so i jumped in today a bit, lets see how good my guess will be :-)
0 · Reply